TY - JOUR
T1 - Novel clinical grading of delayed neurologic sequelae after carbon monoxide poisoning and factors associated with outcome
AU - Kuroda, Hiroshi
AU - Fujihara, Kazuo
AU - Kushimoto, Shigeki
AU - Aoki, Masashi
N1 - Funding Information:
We thank the staff of the Tohoku University Hospital Emergency Medical Center for recruiting and treating patients who experienced acute CO poisoning. This study was supported by a grant-in-aid for scientific research (grant number 24592728 ) from the Ministry of Education, Science, and Technology of Japan .
Publisher Copyright:
© 2015 Elsevier Inc.
PY - 2015/5/1
Y1 - 2015/5/1
N2 - Introduction: Delayed neurologic sequelae (DNS) after carbon monoxide (CO) poisoning manifest as a relapse of neurologic deficits. However, the long-term outcome of DNS has not been fully clarified. Myelin basic protein (MBP) levels in the cerebrospinal fluid (CSF) have been reported to be elevated in DNS. However, the precise timing and clinical value of the CSF examination have not been fully evaluated. We aimed to clarify the long-term outcome and the factors predicting the outcome of DNS and to evaluate the utility of CSF-MBP for predicting the development and severity of DNS. Methods: This work was designed as a single-center, prospective, observational study. We graded DNS severity as Grade 1 (consistent independence), Grade 2 (temporary dependence), or Grade 3 (persistent dependence). We analyzed the percentage categorized in each grade and the parameters associated with outcome. Results: Of 100 patients experiencing acute CO poisoning (median age: 46 years; 69% male), 20 (20%) developed DNS, including six Grade 1 (30%), ten Grade 2 (50%), and four Grade 3 (20%) cases. The Grade 3 patients [median: 77 years; interquartile range (IQR): 76-82] were older than the Grade 1 patients [42; 30-46] (. P<. 0.01); the DNS onset of the Grade 1 patients [median interval after poisoning: 35 days; IQR: 32-56] occurred later than that of the Grade 3 patients [10; 9-13] P<. 0.001) and the Grade 2 patients [25; 23-27] (. P<. 0.05). The CSF-MBP levels of the DNS patients were higher than those of the non-DNS patients (. P<. 0.0001). The 1-month CSF-MBP levels of the Grade 3 patients were higher than those of the Grade 1 patients (. P<. 0.05); the MBP index, defined as [(Age). ×. (1-month CSF-MBP)], was higher in the Grade 3 patients than in the Grade 1 patients (. P<. 0.01). Severe DNS were associated with advanced age (>72.5 years), earlier onset (<18 days), higher 1-month CSF-MBP (>252. pg/ml), and higher MBP index (>20.9 year. ×. ng/ml). Conclusions: Poor DNS outcomes were associated with advanced age and earlier onset. CSF-MBP can serve as a sensitive predictor of both the development and outcomes of DNS.
AB - Introduction: Delayed neurologic sequelae (DNS) after carbon monoxide (CO) poisoning manifest as a relapse of neurologic deficits. However, the long-term outcome of DNS has not been fully clarified. Myelin basic protein (MBP) levels in the cerebrospinal fluid (CSF) have been reported to be elevated in DNS. However, the precise timing and clinical value of the CSF examination have not been fully evaluated. We aimed to clarify the long-term outcome and the factors predicting the outcome of DNS and to evaluate the utility of CSF-MBP for predicting the development and severity of DNS. Methods: This work was designed as a single-center, prospective, observational study. We graded DNS severity as Grade 1 (consistent independence), Grade 2 (temporary dependence), or Grade 3 (persistent dependence). We analyzed the percentage categorized in each grade and the parameters associated with outcome. Results: Of 100 patients experiencing acute CO poisoning (median age: 46 years; 69% male), 20 (20%) developed DNS, including six Grade 1 (30%), ten Grade 2 (50%), and four Grade 3 (20%) cases. The Grade 3 patients [median: 77 years; interquartile range (IQR): 76-82] were older than the Grade 1 patients [42; 30-46] (. P<. 0.01); the DNS onset of the Grade 1 patients [median interval after poisoning: 35 days; IQR: 32-56] occurred later than that of the Grade 3 patients [10; 9-13] P<. 0.001) and the Grade 2 patients [25; 23-27] (. P<. 0.05). The CSF-MBP levels of the DNS patients were higher than those of the non-DNS patients (. P<. 0.0001). The 1-month CSF-MBP levels of the Grade 3 patients were higher than those of the Grade 1 patients (. P<. 0.05); the MBP index, defined as [(Age). ×. (1-month CSF-MBP)], was higher in the Grade 3 patients than in the Grade 1 patients (. P<. 0.01). Severe DNS were associated with advanced age (>72.5 years), earlier onset (<18 days), higher 1-month CSF-MBP (>252. pg/ml), and higher MBP index (>20.9 year. ×. ng/ml). Conclusions: Poor DNS outcomes were associated with advanced age and earlier onset. CSF-MBP can serve as a sensitive predictor of both the development and outcomes of DNS.
KW - Cerebrospinal fluid
KW - Clinical grading
KW - Delayed neurologic sequelae
KW - Myelin basic protein
KW - Outcome
UR - http://www.scopus.com/inward/record.url?scp=84925013830&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925013830&partnerID=8YFLogxK
U2 - 10.1016/j.neuro.2015.03.002
DO - 10.1016/j.neuro.2015.03.002
M3 - Article
C2 - 25757834
AN - SCOPUS:84925013830
SN - 0161-813X
VL - 48
SP - 35
EP - 43
JO - NeuroToxicology
JF - NeuroToxicology
ER -